GIP
SGMO

Granite Investment Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Granite Investment Partners’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-131,634
Closed -$609K – 314
2016
Q3 		$609K Buy
+131,634
New +$669K 0.05% 266

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

Granite Investment Partners's SGMO Position: Q4 2016 in Review

Granite Investment Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2016, closing a stake of 131,634 shares — an estimated $609K sold.

Granite Investment Partners first reported a position in SGMO in Q3 2016 and held it in 1 quarter. The position peaked at $609K in Q3 2016. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • Granite Investment Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2016 after selling out during the quarter.
  • Granite Investment Partners sold 131,634 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $609K.
  • Granite Investment Partners first reported a position in SANGAMO THERAPEUTICS INC in Q3 2016 and held it in 1 quarter.
  • Granite Investment Partners's SANGAMO THERAPEUTICS INC position peaked at $609K in Q3 2016.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on Granite Investment Partners's 13F filing for Q4 2016, filed 1 Feb 2017.